Bacteriophage Therapy Market (Phage Therapy Market; Virus: Campylobacter, Salmonella, Escherichia coli, Listeria, Klebsiella, and Staphylococcus spp., Key Players: Armata Pharmaceuticals, Inc, Micreos, TechnoPhage) Industry Scenario, Market Size, Outlook, Trend and Forecast 2019 – 2030

Chapter 1     Introduction

1.1         Report description

1.2         Scope of Global Phage Therapy Market Segments

1.3         Research methodology

1.3.1       Secondary research

1.3.2       Primary research

1.3.3       In-house data modelling

Chapter 2     Executive Summary

2.1         Quick Snapshot of the Market

2.2         Primary Interviews Details

Chapter 3     market overview

3.1         Market introduction and scope

3.2         LIST OF PIPELINE PRODUCTS

3.3         Porter’s five forces analysis

3.3.1       Bargaining power of Suppliers

3.3.2       Bargaining power of buyers

3.3.3       Substitutes

3.3.4       Threat of new entrants

3.3.5       Competitive Rivalry

3.4         Impact of COVID -19 on Global Phage Therapy Market

3.5         Global Phage Therapy Market Growth Strategy

3.6         PEST Analysis

3.7         Key Trends Analysis and Future Outlook

3.8         Competitive Landscape: Company Market Share Analysis, 2021

3.9         Market Dynamics: Global Phage Therapy Market

3.9.1       Drivers

3.9.1.1         Increased prevalence of foodborne diseases

3.9.1.2         Usage of bacteriophage in the food and beverage industry

3.9.1.3         Bacteriophage is specific to target bacteria

3.9.1.4         Extensive research and developmental

3.9.1.5         Increasing antimicrobial resistance

3.9.2       Restraints

3.9.2.1         Absence of prepared technicians and risk of product failure

3.9.3       Opportunities

3.9.3.1         Market Opportunity for the Key Players in the Coming Years across different geographies

Chapter 4     Global Phage Therapy Market by product, 2019 – 2030 (USD Million)

4.1         Introduction

4.2         Oral

4.2.1       Market size and forecast

4.3         External

4.3.1       Market size and forecast

4.4         Surgical

4.4.1       Market size and forecast

Chapter 5     Global Phage Therapy Market by application, 2019 – 2030 (USD Million)

5.1         Introduction

5.2         Human Medicine

5.2.1       Market size and forecast

5.3         Veterinary Science

5.3.1       Market size and forecast

5.4         Food

5.4.1       Market size and forecast

5.5         Others

5.5.1       Market size and forecast

Chapter 6     Global Phage Therapy Market, by Geography, 2019 – 2030 (USD Million)

6.1         Introduction

6.2         North America

6.2.1       Market size and forecast

6.3         Europe

6.3.1       Market size and forecast

6.4         Asia-Pacific

6.4.1       Market size and forecast

6.5         ROW

6.5.1       Market size and forecast

Chapter 7     Company Profiles

7.1         Eligo Bioscience

7.1.1       Company Overview

7.1.1       Company snapshot

7.1.2       Pipeline Overview:

7.1.3       Business Strategies and Recent Developments

7.2         EnBiotix, Inc

7.2.1       Company Overview

7.2.2       Company snapshot

7.2.3       Pipeline Overview

7.2.4       Business Strategies and recent developments

7.3         InnoPhage, Ltd

7.3.1       Company Overview

7.3.2       Company snapshot

7.3.3       Pipeline Overview

7.3.4       Business Strategies and Recent Development

7.4         iNtODEWorld

7.4.1       Company Overview

7.4.2       Company snapshot

7.4.3       Pipeline Overview

7.4.4       Product Offerings

7.4.5       Business Strategies and Recent Development

7.5         Phage International Inc.

7.5.1       Company Overview

7.5.2       Company snapshot

7.5.3       Pipeline Overview

7.5.4       Business Strategies and Recent Development

7.6         PhagoMed Biopharma GmbH

7.6.1       Company Overview

7.6.2       Company snapshot

7.6.3       Pipeline Overview

7.6.4       Business Strategies and Recent Development

7.7         Adaptive Phage Therapeutics

7.7.1       Company overview

7.7.2       Company Snapshot

7.7.3       Pipeline overview

7.7.4       Business Strategies and Recent Development

7.8         BioMx Inc.

7.8.1       Company Overview

7.8.2       Pipeline Overview

7.9         Contrafect Corporation.

7.9.1       Company Overview

7.9.2       Pipeline Overview

7.9.3       Business Strategies and Recent Developments

7.10       Eliava Biopreparations Ltd.

7.10.1     Company Overview

7.10.2     Company Snapshot

7.10.3     Business Strategies and Recent Developments

7.11       Locus Biosciences

7.11.1     Company Overview

7.11.2     Pipeline Overview

7.11.3     Business Strategy and Recent developments

7.12       Micreos BV

7.12.1     Company Overview

7.12.2     Product Offerings

7.12.3     Pipeline Overview

7.12.4     Business Strategies and Recent Developments

7.13       Microgen Russia

7.13.1     Company overview

7.13.2     Business strategies and recent developments

7.14       Nextbiotics

7.14.1     Company overview

7.14.2     Company snapshot

7.14.3     Pipeline overview

7.15       Phagelux Inc.

7.15.1     Company Overview

7.15.2     Pipeline Overview

7.15.3     Business Strategies and Recent Development

7.16       PhagePro, Inc.

7.16.1     Company Overview

7.16.2     Pipeline Overview

7.17       SNIPR BIOME

7.17.1     Company Overview

7.17.2     Pipeline Overview:

7.17.3     Business Strategies and Recent Developments

7.18       TechnoPhage

7.18.1     Company Overview

7.18.1     Company snapshot

7.18.2     Pipeline Overview

7.18.3     Business Strategies and Recent Developments

7.19       Intralytix, Inc.

7.19.1     Company Overview

7.19.2     Company snapshot

7.19.3     Pipeline Overview

7.19.4     Business Strategies and Recent Development

FIG. 1             Primary Survey Respondent breakdown by Category (%)

FIG. 2             Primary Survey Respondent breakdown by region (%)

FIG. 3             PORTER’S FIVE FORCES ANALYSIS OF Phage Therapy Market

FIG. 4             Global Phage Therapy Market revenue by product type (%), 2019 Vs 2028

FIG. 5             Global Phage Therapy Market revenue by oral segment, 2019 - 2028

FIG. 6             Global Phage Therapy Market revenue by external segment, 2019 - 2028

FIG. 7             Global Phage Therapy Market revenue by surgical segment, 2019 - 2028

FIG. 8             Global Phage Therapy Market revenue by application (%), 2020 Vs 2028

FIG. 9             Global Phage Therapy Market revenue by human medicine segment, 2019 - 2028

FIG. 10          Global Phage Therapy Market revenue by veterinary science segment, 2019 - 2028

FIG. 11          Global Phage Therapy Market revenue by food segment, 2019 - 2028

FIG. 12          Global Phage Therapy Market revenue by others segment, 2019 - 2028

FIG. 13          PHAGE THERAPY MARKET REVENUE BY GEOGRAPHY (%), 2019 Vs 2028

FIG. 14          NORTH AMERICA PHAGE THERAPY MARKET REVENUE, 2019 – 2030 ($ million)

FIG. 15          NORTH AMERICA PHAGE THERAPY MARKET REVENUE by country, 2019 – 2030 ($ million)

FIG. 16          Europe PHAGE THERAPY MARKET REVENUE, 2019 – 2030 ($ million)

FIG. 17          Europe PHAGE THERAPY MARKET REVENUE by country, 2019 – 2030 ($ million)

FIG. 18          Asia pacific PHAGE THERAPY MARKET REVENUE, 2019 – 2030 ($ million)

FIG. 19          Asia pacific PHAGE THERAPY MARKET REVENUE by country, 2019 – 2030 ($ million)

FIG. 20          RoW PHAGE THERAPY MARKET REVENUE, 2019 – 2030 ($ million)

FIG. 21          RoW PHAGE THERAPY MARKET REVENUE by country, 2019 – 2030 ($ million)

TABLE 1       Global Phage Therapy Market, BY GEOGRAPHY, 2020 Vs 2028 ($MILLION)

TABLE 2       Global Phage Therapy Market, BY GEOGRAPHY, 2019 - 2028 ($MILLION)

TABLE 3       NORTH AMERICA Phage Therapy Market BY country, 2019-2028 ($MILLION)

TABLE 4       Europe Phage Therapy Market BY country, 2019-2028 ($MILLION)

TABLE 5       Asia pacific Phage Therapy Market BY country, 2019-2028 ($MILLION)

TABLE 6       Row Phage Therapy Market BY country, 2019-2028 ($MILLION)

TABLE 7       Eligo bioscience

TABLE 8       Enbiotix

TABLE 9       Innophage. ltd

TABLE 10     intodeworld

TABLE 11     Phage International Inc.

TABLE 12     Eligo bioscience